Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-01-11 @ 3:26 PM
Study NCT ID:
NCT03403751
Status:
TERMINATED
Last Update Posted:
2021-10-12
First Post:
2018-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Sponsor:
Atox Bio Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ATB-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None